An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers
Clinical trial NCT03956680 · COMPLETED
Trial details
- NCT number
- NCT03956680
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2024-04-17
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.